Ensysce Biosciences Inc (ENSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Operating Expenses | 626 | 189 | 229 | 248 | 312 |
| Operating Income | -626 | -189 | -229 | -248 | -312 |
| Other Income | 1,272 | 1,180 | 1,134 | 956 | 856 |
| Pre-tax Income | 646 | 990 | 904 | 708 | 545 |
| Income Tax | 227 | 214 | 181 | 130 | 130 |
| Net Income Continuous | 419 | 776 | 723 | 578 | 415 |
| Net Income | $419 | $776 | $723 | $578 | $415 |
| EPS Basic Total Ops | -323.97 | -143.99 | -359.96 | -179.98 | -179.98 |
| EPS Basic Continuous Ops | 249.32 | 462.50 | 432.75 | 345.98 | 249.46 |
| EPS Diluted Total Ops | -323.97 | -143.99 | -359.96 | -179.98 | -179.98 |
| EPS Diluted Continuous Ops | 249.32 | 462.50 | 432.75 | 345.98 | 249.46 |
| EBITDA(a) | $-626 | $-189 | $-229 | $-248 | $-312 |